YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Blood Glucose-Lowering Effects of Mori Folium

상엽의 혈당강하 활성

  • Published : 1995.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Mori Folium(MF) methanol extract and its water soluble fraction showed significant blood glucose lowering effects alloxan-induced hyperglycemic mice. Their hypoglycemic activities seemed to nothing to do with the stimulation of insulin release or insulin-like action, according to our experiments. On the other hand, MF prevents the hyperglycemic responses from an oral load of starch and glucose in vivo. Since complex carbohydrates present in a diet must be degraded to monosaccharides by $\alpha$-glucohydrolase before being absorbed in the gastrointestinal tract, it is thought that blood glucose lowering effects of MF may be related to the inhibition of $\alpha$-glucohydrolase catalyzed enzymatic reaction. In addition, experiments that examined an effect of MF water soluble fraction on gastrointestinal movement showed no significant GI movement inhibitory effect. In conclusion, MF water soluble fraction may possess active component which is a potential candidate as an orally active agent for the treatment of diabetes mellitus.

Keywords

References

  1. Diabetic medicine v.10 α-glucosidase Inhibition as an Adjunct to the Treatment of Type 1 Diabetes Tattersall,R.
  2. Drugs v.44 no.suppl. 3 Nutritional Recommendation for Diabetic Patients and Treatment with α-glucosidase Inhibitor Toeller,M.
  3. Drugs v.44 no.suppl. 3 Oral Antidiabetic Agents: The Emergence of α-glucosidase Inhibitor Levovitz,H.E.
  4. Drugs v.44 no.suppl. 3 Safety Profile of Acarbose, an α-glucosidase Inhibitor Hollander,P.
  5. Planta medical Isolation and hypoglycemic activity of Moran A, a glycoprotein of morus alba Root Barks Hikino,H.;Mizuno,T.;Oshima,Y.;Konno,C.
  6. Chem. Pharm. Bull. v.41 no.7 Two New 2-Aryl-benzofuran Derivatives from Hypoglycemic Activity-Bearing of Morus insignis Basnet,P.;Kadota,S.;Terashima,S.;Shimizu,M.;Namba,T.
  7. Diabetes v.27 no.12 Alloxan Stimulation and Inhibition of Insulin Release from Isolated Rat Isiets of Langerhans Weaver,D.C.;Mcdaniel,M.L.;Naber,S.P.;Barry,D.;Lacy,P.E.
  8. J. Clin. Invest. v.48 Diabetogenic Action of Streptozotocin: Relationship of Dose to Metabolic Response Junod,A.;Lambert,A.E.;Strauffacher,W.;Renold,A.E.
  9. Diabetes v.30 Responses of Neonatal Rat Islets to Streptozotocin Bonner-weir,S.;Trent,D.F.;Honey,R.N.;Weir,G.C.
  10. J. Pharmacol. Exp. Ther. v.241 no.3 Inhibition of Intestinal Disaccharidases and Supression of Blood glucose by a New α-glucohydrolse Inhibitor-MDL 25. 637 Rhinehart,B.L.;Robinson,K.M.;Liu,P.S.;Payne,A.J.;Whetley,M.E.;Wagner,S.R.
  11. Diabetes v.40 New potent α-Glucohydrolase Inhibitor-MDL 73. 945 with Long Duration of Action in Rats Robinson,K.M.;Begovic,M.E.;Rhinehart,B.L.;Heineke,E.W.;Ducep,J.B.;Kastner,P.R.;Marshall,F.N.;Danzin,C.
  12. Proceedings of First International Symposium on Acarbose Clinical studies on acarbose during 5 years Hillebrand,I.;Boehme,K.;Creutzfedt,W.(ed.)